Newave Pharmaceutical Inc
Clinical trials sponsored by Newave Pharmaceutical Inc, explained in plain language.
-
New hope for Tough-to-Treat blood cancers: Head-to-Head drug trial launches
Disease control Recruiting nowThis study tests a new drug, rocbrutinib, against another drug, pirtobrutinib, in adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to prior treatment. About 306 participants will take one of the two pills daily…
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
New pill takes on tough blood cancers in early human trial
Disease control Recruiting nowThis early-phase study tests an experimental oral drug called LP-168 in about 60 adults with several types of B-cell blood cancers (like lymphoma and leukemia) that have returned or not responded to prior treatments. The main goals are to find the safest dose and understand how t…
Phase: PHASE1 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC